[ Price : $8.95]
Aurinia Pharmaceuticals lawsuit against CDER director George Tidmarsh includes screenshots of troubling text messages and emails f...[ Price : $8.95]
CDER director George Tidmarsh resigns after being placed on administrative leave amid an internal ethics investigation and a defam...[ Price : $8.95]
FDA approves UCBs Kygevvi (doxecitine and doxribtimine) for treating thymidine kinase 2 deficiency.[ Price : $8.95]
FDA grants interchangeability designations to Celltrions denosumab biosimilars, Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-...[ Price : $8.95]
FDA issues an updated safety communication confirming long-term post-approval data showing that the Hintermann Series H3 Total Ank...[ Price : $8.95]
Eli Lilly says its investigational weight-loss pill met most criteria for FDAs new national priority voucher program and could be ...[ Price : $8.95]
Johnson & Johnson files a supplemental BLA seeking to expand the use of its biologic therapy Stelara (ustekinumab) to treat childr...[ Price : $8.95]
CBER director Vinay Prasad says FDA is preparing to introduce a new, accelerated pathway for approving custom gene-editing therapi...